CD8A and neoplasm: Given that CD8+ T lymphocytes are critical effector cells in the body's antitumor immune response, capable of directly killing tumor cells and modulating the functions of other immune cells through cytokine secretion, the significant increase in the proportion of CD8+ T cells reflects an enhancement in local immune activity within the tumor tissue [47, 48, 49].